Currently available prostanoids for the treatment of glaucoma and ocular hypertension: A review. [PDF]
Benitez B+3 more
europepmc +1 more source
Dysregulation of neuroprotective lipoxin pathway in astrocytes in response to cytokines and ocular hypertension. [PDF]
Karnam S+6 more
europepmc +1 more source
Bioequivalence of Preservative-Free and Preserved Omidenepag Isopropyl 0.002% Ophthalmic Solutions in Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Phase 3 DAISY Study. [PDF]
Aihara M+3 more
europepmc +1 more source
Abnormalies of scotopic electroretinography in rats with laser-induced ocular hypertension [PDF]
Sy Li, Dkc Tay, HH Chan, Kwok–Fai So
openalex
Clinical prediction nomogram for steroid-induced ocular hypertension risk in patients with intravitreal dexamethasone implant. [PDF]
Cho WJ+5 more
europepmc +1 more source
Downregulation of SARM1 Protects Retinal Ganglion Cell Axonal and Somal Degeneration Via JNK Activation in a Glaucomatous Model of Ocular Hypertension. [PDF]
Zhang X+5 more
europepmc +1 more source
Comparing 24-hour IOP fluctuation slope curve between newly diagnosed ocular hypertension and primary open-angle glaucoma. [PDF]
Zhang Q+9 more
europepmc +1 more source
Autophagy deficiency protects against ocular hypertension and glaucoma. [PDF]
Dixon A+6 more
europepmc +1 more source
Ten-Year Effectiveness and Safety of Trabecular Micro-Bypass Stent Implantation with Cataract Surgery in Patients with Glaucoma or Ocular Hypertension. [PDF]
Neuhann TH, Neuhann RT, Hornbeak DM.
europepmc +1 more source
Impact of Acute Ocular Hypertension on Retinal Ganglion Cell Loss in Mice. [PDF]
Xuan M+8 more
europepmc +1 more source